ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19

Stock Information for ARCA biopharma Inc.

Loading

Please wait while we load your information from QuoteMedia.